Li-Fraumeni Syndrome

Definition

The TP53 gene encodes the 'guardian of the genome' p53 protein, which triggers cell cycle arrest, DNA repair, or apoptosis in response to cellular stress and DNA damage. Germline heterozygous loss of function mutations cause Li-Fraumeni syndrome, which confers a very high lifetime risk (up to ~90% in women) of multiple cancer types in childhood and adulthood, including sarcoma, breast cancer, brain tumors, adrenocortical carcinoma, and leukemia.

Gene/region examined

TP53 - Exon 2, TP53 - Exon 3, TP53 - Exon 4, TP53 - Exon 5, TP53 - Exon 6, TP53 - Exon 7, TP53 - Exon 8, TP53 - Exon 9, TP53 - Exon 10, TP53 - Exon 11

Method

Sequence analysis

Accepted sample types

EDTA blood, AF, CVS

Inheritance

Hereditary (germline), autosomal dominant; somatic TP53 mutations are also very common in sporadic tumors, but this test targets germline analysis.

Related Tests